TY - JOUR AU - Costa, L. J. AU - Brill, I. K. AU - Omel, J. AU - Godby, K. AU - Kumar, S. K. AU - Brown, E. E. PY - 2017 DA - 2017// TI - Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States JO - Blood Adv VL - 1 UR - https://doi.org/10.1182/bloodadvances.2016002493 DO - 10.1182/bloodadvances.2016002493 ID - Costa2017 ER - TY - JOUR AU - Chen, Y. AU - Wang, H. AU - Kantarjian, H. AU - Cortes, J. PY - 2013 DA - 2013// TI - Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009 JO - Leuk Lymphoma VL - 54 UR - https://doi.org/10.3109/10428194.2012.745525 DO - 10.3109/10428194.2012.745525 ID - Chen2013 ER - TY - JOUR AU - Noens, L. AU - Hensen, M. AU - Kucmin-Bemelmans, I. AU - Lofgren, C. AU - Gilloteau, I. AU - Vrijens, B. PY - 2014 DA - 2014// TI - Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2012.082511 DO - 10.3324/haematol.2012.082511 ID - Noens2014 ER - TY - JOUR AU - Kumar, S. K. AU - Vij, R. AU - Noga, S. J. PY - 2017 DA - 2017// TI - Treating multiple myeloma patients with oral therapies JO - Clin Lymphoma Myeloma Leuk VL - 17 UR - https://doi.org/10.1016/j.clml.2017.02.024 DO - 10.1016/j.clml.2017.02.024 ID - Kumar2017 ER - TY - JOUR AU - Mandal, R. AU - Bolt, D. M. AU - Shah, B. K. PY - 2013 DA - 2013// TI - Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US JO - Acta Oncol VL - 52 UR - https://doi.org/10.3109/0284186X.2012.707784 DO - 10.3109/0284186X.2012.707784 ID - Mandal2013 ER - TY - JOUR AU - Ailawadhi, S. AU - Frank, R. D. AU - Advani, P. AU - Swaika, A. AU - Temkit, M. AU - Menghani, R. PY - 2017 DA - 2017// TI - Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis JO - Cancer Med VL - 6 UR - https://doi.org/10.1002/cam4.1246 DO - 10.1002/cam4.1246 ID - Ailawadhi2017 ER - TY - JOUR AU - Gupta, S. h. a. l. o. o. AU - Abouzaid, S. a. f. i. y. a. AU - Liebert, R. y. a. n. AU - Parikh, K. e. j. a. l. AU - Ung, B. r. i. a. n. AU - Rosenberg, A. a. r. o. n. S. PY - 2018 DA - 2018// TI - Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma JO - Clinical Lymphoma Myeloma and Leukemia VL - 18 UR - https://doi.org/10.1016/j.clml.2018.01.006 DO - 10.1016/j.clml.2018.01.006 ID - Gupta2018 ER - TY - JOUR AU - Ibrahim, A. R. AU - Eliasson, L. AU - Apperley, J. F. PY - 2011 DA - 2011// TI - Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-10-309807 DO - 10.1182/blood-2010-10-309807 ID - Ibrahim2011 ER - TY - JOUR AU - Ganesan, P. AU - Sagar, T. G. AU - Dubashi, B. PY - 2011 DA - 2011// TI - Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia JO - Am J Hematol VL - 86 UR - https://doi.org/10.1002/ajh.22019 DO - 10.1002/ajh.22019 ID - Ganesan2011 ER - TY - JOUR AU - Cramer, J. A. AU - Roy, A. AU - Burrell, A. PY - 2008 DA - 2008// TI - Medication compliance and persistence: terminology and definitions JO - Value Health VL - 11 UR - https://doi.org/10.1111/j.1524-4733.2007.00213.x DO - 10.1111/j.1524-4733.2007.00213.x ID - Cramer2008 ER - TY - JOUR AU - Hall, A. E. AU - Paul, C. AU - Bryant, J. PY - 2016 DA - 2016// TI - To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients JO - Crit Rev Oncol Hematol VL - 97 UR - https://doi.org/10.1016/j.critrevonc.2015.08.025 DO - 10.1016/j.critrevonc.2015.08.025 ID - Hall2016 ER - TY - JOUR AU - Ruddy, K. AU - Mayer, E. AU - Partridge, A. PY - 2009 DA - 2009// TI - Patient adherence and persistence with oral anticancer treatment JO - CA Cancer J Clin VL - 59 UR - https://doi.org/10.3322/caac.20004 DO - 10.3322/caac.20004 ID - Ruddy2009 ER - TY - JOUR AU - Spoelstra, S. L. AU - Rittenberg, C. N. PY - 2015 DA - 2015// TI - Assessment and measurement of medication adherence: oral agents for cancer JO - Clin J Oncol Nurs VL - 19 UR - https://doi.org/10.1188/15.S1.CJON.47-52 DO - 10.1188/15.S1.CJON.47-52 ID - Spoelstra2015 ER - TY - JOUR AU - Breccia, M. AU - Efficace, F. AU - Alimena, G. PY - 2011 DA - 2011// TI - Imatinib treatment in chronic myelogenous leukemia: what have we learned so far? JO - Cancer Lett VL - 300 UR - https://doi.org/10.1016/j.canlet.2010.10.018 DO - 10.1016/j.canlet.2010.10.018 ID - Breccia2011 ER - TY - JOUR AU - Gater, A. AU - Heron, L. AU - Abetz-Webb, L. PY - 2012 DA - 2012// TI - Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia JO - Leuk Res VL - 36 UR - https://doi.org/10.1016/j.leukres.2012.01.021 DO - 10.1016/j.leukres.2012.01.021 ID - Gater2012 ER - TY - JOUR AU - Breccia, M. AU - Efficace, F. AU - Sica, S. PY - 2015 DA - 2015// TI - Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients JO - Leuk Res VL - 39 UR - https://doi.org/10.1016/j.leukres.2015.07.004 DO - 10.1016/j.leukres.2015.07.004 ID - Breccia2015 ER - TY - JOUR AU - Matza, L. S. AU - Park, J. AU - Coyne, K. S. AU - Skinner, E. P. AU - Malley, K. G. AU - Wolever, R. Q. PY - 2009 DA - 2009// TI - Derivation and validation of the ASK-12 adherence barrier survey JO - Ann Pharmacother VL - 43 UR - https://doi.org/10.1345/aph.1M174 DO - 10.1345/aph.1M174 ID - Matza2009 ER - TY - JOUR AU - Hahn, S. R. AU - Park, J. AU - Skinner, E. P. PY - 2008 DA - 2008// TI - Development of the ASK-20 adherence barrier survey JO - Curr Med Res Opin VL - 24 UR - https://doi.org/10.1185/03007990802174769 DO - 10.1185/03007990802174769 ID - Hahn2008 ER - TY - JOUR AU - Morisky, D. E. AU - Green, L. W. AU - Levine, D. M. PY - 1986 DA - 1986// TI - Concurrent and predictive validity of a self-reported measure of medication adherence JO - Med Care VL - 24 UR - https://doi.org/10.1097/00005650-198601000-00007 DO - 10.1097/00005650-198601000-00007 ID - Morisky1986 ER - TY - JOUR AU - Eliasson, L. AU - Clifford, S. AU - Barber, N. AU - Marin, D. PY - 2011 DA - 2011// TI - Exploring chronic myeloid leukemia patients’ reasons for not adhering to the oral anticancer drug imatinib as prescribed JO - Leuk Res VL - 35 UR - https://doi.org/10.1016/j.leukres.2010.10.017 DO - 10.1016/j.leukres.2010.10.017 ID - Eliasson2011 ER - TY - JOUR AU - Morisky, D. E. AU - Ang, A. AU - Krousel-Wood, M. AU - Ward, H. J. PY - 2008 DA - 2008// TI - Predictive validity of a medication adherence measure in an outpatient setting JO - J Clin Hypertens VL - 10 UR - https://doi.org/10.1111/j.1751-7176.2008.07572.x DO - 10.1111/j.1751-7176.2008.07572.x ID - Morisky2008 ER - TY - JOUR AU - Noens, L. AU - Lierde, M. A. AU - Bock, R. PY - 2009 DA - 2009// TI - Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-12-196543 DO - 10.1182/blood-2008-12-196543 ID - Noens2009 ER - TY - STD TI - ASK-12 Survey. http://www.cynosurehealth.org/wwwroot/userfiles/documents/204/ask-12-survey-overview.pdf. Accessed 6 Aug 2018. UR - http://www.cynosurehealth.org/wwwroot/userfiles/documents/204/ask-12-survey-overview.pdf ID - ref23 ER -